Primary Job Title Board member Primary Organization 
Ranbaxy Laboratories
Gender Male
Investor Type
Tony was the Chairman of the privately-held MedPointe Pharmaceuticals Inc., a specialty pharmaceutical company based in Somerset, New Jersey, until its acquisition by Meda AB of Sweden in August 2007.
Tony previously served as Chief Executive Officer of MedPointe from 2001 to 2006. Between 1995 and 2000, he worked for the Warner-Lambert Company
of Morris Plains, New Jersey.
Starting as President of Warner-Lambert’s Parke-Davis (North America) unit, Tony was promoted to Executive Vice President and President of its global Pharmaceutical Sector in 1996. Tony received Ph.D. in Physical Chemistry from Churchill College, University of Cambridge and graduated from the University of York with a B.A. honors degree in Chemistry.
He served as a member of the board of directors of Slate until Slate’s acquisition in December 2011. Prior to Warner-Lambert, Tony spent over 20 years with Schering-Plough in 26 different countries.
He currently serves on the board of Ranbaxy Laboratories Ltd., India’s largest pharmaceutical company, as well as of several other privately owned healthcare companies.
